Skip to main content

Table 2 Quality of bias assessment of the included studies according to the Cochrane guidelines

From: Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials

Study

Sequence generation

Allocation concealment

Blinding of participants, personnel and outcome assessors

Incomplete outcome data

Selective outcome reporting

Other sources of bias

Balan et al. (1994) [18]

U

U

L

L

L

U

Battezzati et al. (1993) [21]

L

L

L

L

L

L

Braga et al. (2009) [22]

U

U

U

L

L

U

Carulli et al. (1981) [32]

U

U

U

L

L

U

Fromm et al. (1983) [23]

U

U

U

L

L

U

Gianturco et al. (2013) [39]

L

L

U

L

L

U

Leuschner et al. (2010) [40]

U

U

U

L

L

U

Lindenthal et al. (2002) [33]

U

U

H

L

L

U

Méndez-Sánchez et al. (2004) [19]

L

L

U

L

L

U

Miettinen et al. (1995) [20]

U

U

U

L

L

U

Nakagawa et al. (1977) [37]

U

L

L

L

L

U

Parés et al. (2000) [34]

U

L

L

L

L

U

Poupon et al. (1990) [35]

U

U

U

L

L

U

Poupon et al. (1993) [38]

H

U

U

L

L

U

Vuoristo et al. (1995) [36]

U

U

U

L

L

U

  1. L low risk of bias, H high risk of bias, U unclear risk of bias